文献速递神经肿瘤

烷化剂化疗后切除的1p/19q共缺失胶质瘤的组织病理学研究

Histopathological investigation of the 1p/19q-codeleted gliomas resected following alkylating agent chemotherapy.
PubMed 文献 · J Neurooncol · 2021-10-31

本研究纳入14例烷化剂化疗后肿瘤体积缩小并切除的1p/19q共缺失胶质瘤,与化疗前标本对比。化疗后常见稀疏胶质背景和大量泡沫细胞浸润,Ki-67/MIB-1指数下降、CD68+细胞增多;CD68+细胞增加率与预后负相关,CD163+细胞、M2/M1+M2比值及胶质瘤干细胞比例在化疗后升高且与预后负相关。结论认为胶质瘤干细胞联合M2巨噬细胞构成耐药和复发机制。

要点

  • 化疗后1p/19q共缺失胶质瘤呈现稀疏胶质背景和泡沫细胞浸润。
  • 化疗后Ki-67/MIB-1指数下降、CD68+细胞增多。
  • 化疗后胶质瘤干细胞比例及M2/M1+M2比值升高,与预后负相关。

核心结论

  • 胶质瘤干细胞联合M2巨噬细胞构成1p/19q共缺失胶质瘤对烷化剂化疗耐药及化疗后复发的机制。

研究设计与样本

  • 纳入14例烷化剂化疗后肿瘤体积缩小并切除的1p/19q共缺失胶质瘤,与化疗前标本进行对比,采用苏木精-伊红染色及Ki-67/MIB-1、CD68、CD163、nestin和CD133免疫组化评估。

主要发现

  • 化疗后最常见的组织学表现包括稀疏胶质背景和大量泡沫细胞浸润。
  • 化疗后Ki-67/MIB-1指数下降,CD68+细胞数量增加。
  • 化疗后/化疗前标本中CD68+细胞增加率与患者预后呈负相关,但与肿瘤反应无相关性。
  • 化疗后CD163+细胞数量、M2/M1+M2比值及胶质瘤干细胞占总肿瘤细胞比例升高,且化疗后标本中这些指标与患者预后呈负相关。
  • 化疗前和化疗后标本中M2/M1+M2比值与胶质瘤干细胞比例均存在相关性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Lower grade gliomas with 1p/19q codeletion are often responsive to chemotherapy, and several of these have been treated using upfront chemotherapy and subsequent resection following tumor volume decrease. This study aimed to elucidate the histological changes and the mechanism of recurrence after alkylating agent chemotherapy in 1p/19-codeleted gliomas. METHODS: Fourteen 1p/19q-codeleted gliomas resected following tumor volume decrease after alkylating agent chemotherapy were included and compared with their pre-chemotherapy specimens. Histological changes were investigated using hematoxylin-eosin staining, and changes in proliferative activity, status of glioma stem cells (GSCs), and tumor-infiltrating macrophages were assessed using immunohistochemistry for Ki-67/MIB-1, CD68 as a pan-macrophage/monocyte marker, CD163 as a presumed marker of M2 polarity, and nestin and CD133 as markers of GSCs. RESULTS: The most frequent histological findings following chemotherapy included a sparse glial background and abundant foamy cell infiltration. The Ki-67/MIB-1 index decreased and the number of CD68 + cells increased after chemotherapy. The increasing rate of CD68 + cells in the post-/pre-chemotherapy specimens was inversely correlated with patient prognosis but not tumor response. The number of CD163 + cells, M2/M1 + M2 ratio, and the ratio of GSCs to total tumor cells increased after chemotherapy, and those in the post-chemotherapy specimens were negatively correlated with patient prognosis. There was a correlation between the M2/M1 + M2 ratio and the ratio of GSCs in both pre- and post-chemotherapy specimens. CONCLUSION: GSCs in conjunction with M2 macrophages constitute the mechanism of resistance to and recurrence after alkylating agent chemotherapy in 1p/19q-codeleted gliomas.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Kanazawa T, Ohara K, Kitamura Y, et al. Histopathological investigation of the 1p/19q-codeleted gliomas resected following alkylating agent chemotherapy. J Neurooncol. 2021. PMID: 34718935. doi:10.1007/s11060-021-03855-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。